The global Oral Drug Delivery market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Oral drug delivery is the most preferred administration route due to noninvasive, high patient compliance, convenient to handle, and does not require any specific sterile conditions. However, some of the drugs administered orally face several physical, biological, and biochemical barriers which lower the therapeutic efficacy of the drugs before getting absorbed into the systemic circulation. The utilization of nanocarriers for oral drug delivery overcome abovementioned barriers and considered as an alternative strategy to address the drawbacks of oral drug delivery. In this chapter, the recent advancement of nanocarriers in oral drug delivery application for the treatment of various diseases is summarized. Furthermore, the chapter explains how different nanocarriers designing technology enhance the therapeutic potential to overcome the various barriers such as physical, biological, and biochemical. Although, in recent years, several nanocarrier-based drug delivery technologies have been evolved and showing promising results but still it is far from the real utilization in the clinic.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淥ral Drug Delivery Industry Forecast鈥� looks at past sales and reviews total world Oral Drug Delivery sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Drug Delivery sales for 2025 through 2031. With Oral Drug Delivery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Drug Delivery industry.
This Insight Report provides a comprehensive analysis of the global Oral Drug Delivery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Drug Delivery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Oral Drug Delivery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Drug Delivery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Drug Delivery.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Drug Delivery market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Diffusion Controlled Release System
Dissolution Controlled Release System
Ion Exchange Resins Controlled Release
Hydro-dynamically Balanced Drug Delivery System
Osmotically Controlled Release System
Dissolution & Diffusion Controlled Release System
Segmentation by Application:
Hospitals
Clinics
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AstraZeneca Plc.
Mylan N.V.
Sanofi
F. Hoffman-La-Roche Ltd.
Bristol-Myers Squibb Company
Sun Pharmaceuticals Industries Ltd
Abbott Laboratories
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Vectura Group plc.
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oral Drug Delivery market?
What factors are driving Oral Drug Delivery market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Drug Delivery market opportunities vary by end market size?
How does Oral Drug Delivery break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Drug Delivery Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Oral Drug Delivery by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Oral Drug Delivery by Country/Region, 2020, 2024 & 2031
2.2 Oral Drug Delivery Segment by Type
2.2.1 Diffusion Controlled Release System
2.2.2 Dissolution Controlled Release System
2.2.3 Ion Exchange Resins Controlled Release
2.2.4 Hydro-dynamically Balanced Drug Delivery System
2.2.5 Osmotically Controlled Release System
2.2.6 Dissolution & Diffusion Controlled Release System
2.3 Oral Drug Delivery Sales by Type
2.3.1 Global Oral Drug Delivery Sales Market Share by Type (2020-2025)
2.3.2 Global Oral Drug Delivery Revenue and Market Share by Type (2020-2025)
2.3.3 Global Oral Drug Delivery Sale Price by Type (2020-2025)
2.4 Oral Drug Delivery Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Other
2.5 Oral Drug Delivery Sales by Application
2.5.1 Global Oral Drug Delivery Sale Market Share by Application (2020-2025)
2.5.2 Global Oral Drug Delivery Revenue and Market Share by Application (2020-2025)
2.5.3 Global Oral Drug Delivery Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Oral Drug Delivery Breakdown Data by Company
3.1.1 Global Oral Drug Delivery Annual Sales by Company (2020-2025)
3.1.2 Global Oral Drug Delivery Sales Market Share by Company (2020-2025)
3.2 Global Oral Drug Delivery Annual Revenue by Company (2020-2025)
3.2.1 Global Oral Drug Delivery Revenue by Company (2020-2025)
3.2.2 Global Oral Drug Delivery Revenue Market Share by Company (2020-2025)
3.3 Global Oral Drug Delivery Sale Price by Company
3.4 Key Manufacturers Oral Drug Delivery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Drug Delivery Product Location Distribution
3.4.2 Players Oral Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Oral Drug Delivery by Geographic Region
4.1 World Historic Oral Drug Delivery Market Size by Geographic Region (2020-2025)
4.1.1 Global Oral Drug Delivery Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Oral Drug Delivery Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Oral Drug Delivery Market Size by Country/Region (2020-2025)
4.2.1 Global Oral Drug Delivery Annual Sales by Country/Region (2020-2025)
4.2.2 Global Oral Drug Delivery Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oral Drug Delivery Sales Growth
4.4 APAC Oral Drug Delivery Sales Growth
4.5 Europe Oral Drug Delivery Sales Growth
4.6 Middle East & Africa Oral Drug Delivery Sales Growth
5 Americas
5.1 Americas Oral Drug Delivery Sales by Country
5.1.1 Americas Oral Drug Delivery Sales by Country (2020-2025)
5.1.2 Americas Oral Drug Delivery Revenue by Country (2020-2025)
5.2 Americas Oral Drug Delivery Sales by Type (2020-2025)
5.3 Americas Oral Drug Delivery Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Drug Delivery Sales by Region
6.1.1 APAC Oral Drug Delivery Sales by Region (2020-2025)
6.1.2 APAC Oral Drug Delivery Revenue by Region (2020-2025)
6.2 APAC Oral Drug Delivery Sales by Type (2020-2025)
6.3 APAC Oral Drug Delivery Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Drug Delivery by Country
7.1.1 Europe Oral Drug Delivery Sales by Country (2020-2025)
7.1.2 Europe Oral Drug Delivery Revenue by Country (2020-2025)
7.2 Europe Oral Drug Delivery Sales by Type (2020-2025)
7.3 Europe Oral Drug Delivery Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Drug Delivery by Country
8.1.1 Middle East & Africa Oral Drug Delivery Sales by Country (2020-2025)
8.1.2 Middle East & Africa Oral Drug Delivery Revenue by Country (2020-2025)
8.2 Middle East & Africa Oral Drug Delivery Sales by Type (2020-2025)
8.3 Middle East & Africa Oral Drug Delivery Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Drug Delivery
10.3 Manufacturing Process Analysis of Oral Drug Delivery
10.4 Industry Chain Structure of Oral Drug Delivery
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Drug Delivery Distributors
11.3 Oral Drug Delivery Customer
12 World Forecast Review for Oral Drug Delivery by Geographic Region
12.1 Global Oral Drug Delivery Market Size Forecast by Region
12.1.1 Global Oral Drug Delivery Forecast by Region (2026-2031)
12.1.2 Global Oral Drug Delivery Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Oral Drug Delivery Forecast by Type (2026-2031)
12.7 Global Oral Drug Delivery Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 AstraZeneca Plc.
13.1.1 AstraZeneca Plc. Company Information
13.1.2 AstraZeneca Plc. Oral Drug Delivery Product Portfolios and Specifications
13.1.3 AstraZeneca Plc. Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AstraZeneca Plc. Main Business Overview
13.1.5 AstraZeneca Plc. Latest Developments
13.2 Mylan N.V.
13.2.1 Mylan N.V. Company Information
13.2.2 Mylan N.V. Oral Drug Delivery Product Portfolios and Specifications
13.2.3 Mylan N.V. Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mylan N.V. Main Business Overview
13.2.5 Mylan N.V. Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Oral Drug Delivery Product Portfolios and Specifications
13.3.3 Sanofi Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 F. Hoffman-La-Roche Ltd.
13.4.1 F. Hoffman-La-Roche Ltd. Company Information
13.4.2 F. Hoffman-La-Roche Ltd. Oral Drug Delivery Product Portfolios and Specifications
13.4.3 F. Hoffman-La-Roche Ltd. Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 F. Hoffman-La-Roche Ltd. Main Business Overview
13.4.5 F. Hoffman-La-Roche Ltd. Latest Developments
13.5 Bristol-Myers Squibb Company
13.5.1 Bristol-Myers Squibb Company Company Information
13.5.2 Bristol-Myers Squibb Company Oral Drug Delivery Product Portfolios and Specifications
13.5.3 Bristol-Myers Squibb Company Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Bristol-Myers Squibb Company Main Business Overview
13.5.5 Bristol-Myers Squibb Company Latest Developments
13.6 Sun Pharmaceuticals Industries Ltd
13.6.1 Sun Pharmaceuticals Industries Ltd Company Information
13.6.2 Sun Pharmaceuticals Industries Ltd Oral Drug Delivery Product Portfolios and Specifications
13.6.3 Sun Pharmaceuticals Industries Ltd Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sun Pharmaceuticals Industries Ltd Main Business Overview
13.6.5 Sun Pharmaceuticals Industries Ltd Latest Developments
13.7 Abbott Laboratories
13.7.1 Abbott Laboratories Company Information
13.7.2 Abbott Laboratories Oral Drug Delivery Product Portfolios and Specifications
13.7.3 Abbott Laboratories Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Abbott Laboratories Main Business Overview
13.7.5 Abbott Laboratories Latest Developments
13.8 Merck & Co. Inc.
13.8.1 Merck & Co. Inc. Company Information
13.8.2 Merck & Co. Inc. Oral Drug Delivery Product Portfolios and Specifications
13.8.3 Merck & Co. Inc. Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Merck & Co. Inc. Main Business Overview
13.8.5 Merck & Co. Inc. Latest Developments
13.9 Novartis AG
13.9.1 Novartis AG Company Information
13.9.2 Novartis AG Oral Drug Delivery Product Portfolios and Specifications
13.9.3 Novartis AG Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Novartis AG Main Business Overview
13.9.5 Novartis AG Latest Developments
13.10 Pfizer Inc.
13.10.1 Pfizer Inc. Company Information
13.10.2 Pfizer Inc. Oral Drug Delivery Product Portfolios and Specifications
13.10.3 Pfizer Inc. Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Pfizer Inc. Main Business Overview
13.10.5 Pfizer Inc. Latest Developments
13.11 Vectura Group plc.
13.11.1 Vectura Group plc. Company Information
13.11.2 Vectura Group plc. Oral Drug Delivery Product Portfolios and Specifications
13.11.3 Vectura Group plc. Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Vectura Group plc. Main Business Overview
13.11.5 Vectura Group plc. Latest Developments
13.12 GlaxoSmithKline plc.
13.12.1 GlaxoSmithKline plc. Company Information
13.12.2 GlaxoSmithKline plc. Oral Drug Delivery Product Portfolios and Specifications
13.12.3 GlaxoSmithKline plc. Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 GlaxoSmithKline plc. Main Business Overview
13.12.5 GlaxoSmithKline plc. Latest Developments
13.13 Johnson & Johnson Services, Inc
13.13.1 Johnson & Johnson Services, Inc Company Information
13.13.2 Johnson & Johnson Services, Inc Oral Drug Delivery Product Portfolios and Specifications
13.13.3 Johnson & Johnson Services, Inc Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Johnson & Johnson Services, Inc Main Business Overview
13.13.5 Johnson & Johnson Services, Inc Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
